Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-27 Purchase | 2025-01-31 5:06 pm | Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director | 12,400 | $0.7975 | $9,889 | 47,369 (Indirect Direct) | View |
| 2025-01-27 Purchase | 2025-01-29 5:05 pm | Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer | 87,200 | $0.7975 | $69,542 | 107,200 (Indirect) | View |
| 2025-01-27 Purchase | 2025-01-29 4:24 pm | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 124,500 | $0.7975 | $99,289 | 265,720 (Indirect Direct) | View |
| 2025-01-27 Purchase | 2025-01-29 4:20 pm | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 43,500 | $0.7975 | $34,691 | 72,559 (Indirect Direct) | View |
| 2024-02-07 Purchase | 2024-02-08 4:30 pm | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 21,000 | $2.4536 | $51,526 | 139,702 (Indirect Direct) | View |
| 2024-02-06 Purchase | 2024-02-07 4:22 pm | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 20,000 | $2.5252 | $50,504 | 118,702 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-07-24 Option Award | 2025-07-28 4:36 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer | 1,366,046 | $0 | 1,376,478 (Direct) | View |
| 2025-07-24 Option Award | 2025-07-28 4:34 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 1,401,650 | $0 | 1,412,082 (Direct) | View |
| 2025-07-24 Option Award | 2025-07-28 4:32 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer | 1,659,185 | $0 | 1,672,087 (Direct) | View |
| 2025-07-24 Option Award | 2025-07-28 4:30 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | SKIBSTED RUSSELL Chief Financial Officer | 1,775,044 | $0 | 1,803,044 (Direct) | View |
| 2025-07-24 Option Award | 2025-07-28 4:28 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 1,813,133 | $0 | 1,821,016 (Direct) | View |
| 2025-07-24 Option Award | 2025-07-28 4:25 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer | 1,822,471 | $0 | 1,922,471 (Direct) | View |
| 2025-07-24 Option Award | 2025-07-28 4:21 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Neal James R Director | 175,299 | $0 | 206,505 (Direct) | View |
| 2025-07-24 Option Award | 2025-07-28 4:19 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director | 175,299 | $0 | 206,505 (Direct) | View |
| 2025-07-24 Option Award | 2025-07-28 4:17 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Pannu Geraldine Director | 175,299 | $0 | 206,505 (Direct) | View |
| 2025-07-24 Option Award | 2025-07-28 4:16 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director | 175,299 | $0 | 206,505 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-11 5:22 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 14,482 | $0 | 82,227 (Direct) | View |
| 2025-04-01 Tax Withholding | 2025-04-11 5:22 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 4,814 | $0.412 | 82,227 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-11 5:20 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer | 14,482 | $0 | 34,674 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-11 5:17 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer | 15,059 | $0 | 40,294 (Direct) | View |
| 2025-04-01 Tax Withholding | 2025-04-11 5:17 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer | 3,311 | $0.412 | 40,294 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-11 5:16 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 17,272 | $0 | 277,647 (Direct) | View |
| 2025-04-01 Tax Withholding | 2025-04-11 5:16 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 5,345 | $0.412 | 277,647 (Direct) | View |
| 2025-01-29 Option Award(A) | 2025-02-18 5:59 pm | 2025-01-29 2030-01-29 | Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director | 18,600 | $0 | 65,969 (Indirect) | View |
| 2025-01-29 Option Award(A) | 2025-02-18 5:57 pm | 2025-01-29 2030-01-29 | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 186,750 | $0 | 452,470 (Direct) | View |
| 2025-01-29 Option Award(A) | 2025-02-18 5:54 pm | 2025-01-29 2030-01-29 | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 65,250 | $0 | 137,809 (Indirect) | View |
| 2025-01-29 Option Award(A) | 2025-02-18 5:53 pm | 2025-01-29 2030-01-29 | Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer | 130,800 | $0 | 238,000 (Indirect) | View |
| 2024-09-03 Option Award | 2024-09-18 4:51 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director | 31,206 | $0 | 31,206 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-18 4:50 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Pannu Geraldine Director | 31,206 | $0 | 31,206 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-18 4:48 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Neal James R Director | 31,206 | $0 | 31,206 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-18 4:47 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director | 31,206 | $0 | 31,206 (Direct) | View |
| 2024-07-10 Tax Withholding | 2024-08-02 5:34 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer | 225 | $1.71 | 135,945 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-02 5:34 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer | 6,466 | $0 | 135,945 (Direct) | View |
| 2024-04-05 Exercise | 2024-08-02 5:34 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer | 2,319 | $0 | 135,945 (Direct) | View |
| 2024-04-05 Tax Withholding | 2024-08-02 5:34 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer | 368 | $2.79 | 135,945 (Direct) | View |
| 2024-07-10 Tax Withholding | 2024-08-02 5:31 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 282 | $1.71 | 120,438 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-02 5:31 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 6,154 | $0 | 120,438 (Direct) | View |
| 2024-04-05 Exercise | 2024-08-02 5:31 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 2,319 | $0 | 120,438 (Direct) | View |
| 2024-04-05 Tax Withholding | 2024-08-02 5:31 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 518 | $2.79 | 120,438 (Direct) | View |
| 2024-07-10 Tax Withholding | 2024-08-02 5:28 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 271 | $1.71 | 124,985 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-02 5:28 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 5,426 | $0 | 124,985 (Direct) | View |
| 2024-04-05 Exercise | 2024-08-02 5:28 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 2,319 | $0 | 124,985 (Direct) | View |
| 2024-04-05 Tax Withholding | 2024-08-02 5:28 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 539 | $2.79 | 124,985 (Direct) | View |
| 2024-07-10 Tax Withholding | 2024-08-02 5:12 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer | 220 | $1.71 | 116,118 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-02 5:12 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer | 5,426 | $0 | 116,118 (Direct) | View |
| 2024-04-05 Exercise | 2024-08-02 5:12 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer | 2,319 | $0 | 116,118 (Direct) | View |
| 2024-04-05 Tax Withholding | 2024-08-02 5:12 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer | 368 | $2.79 | 116,118 (Direct) | View |
| 2024-07-10 Tax Withholding | 2024-08-02 5:09 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 282 | $1.71 | 237,395 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-02 5:09 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 6,466 | $0 | 237,395 (Direct) | View |
| 2024-04-05 Exercise | 2024-08-02 5:09 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 2,319 | $0 | 237,395 (Direct) | View |
| 2024-04-05 Tax Withholding | 2024-08-02 5:09 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 518 | $2.79 | 237,395 (Direct) | View |
| 2024-07-16 Option Award | 2024-07-18 4:46 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | SKIBSTED RUSSELL Chief Financial Officer | 28,000 | $0 | 28,000 (Direct) | View |
| 2024-01-01 Exercise | 2024-04-12 5:01 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 1,675 | $0 | 160,192 (Direct) | View |
| 2024-01-01 Tax Withholding | 2024-04-12 5:01 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 518 | $2.79 | 160,192 (Direct) | View |
| 2024-01-01 Exercise | 2024-04-12 4:57 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 1,675 | $0 | 30,157 (Direct) | View |
| 2024-01-01 Tax Withholding | 2024-04-12 4:57 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 518 | $2.79 | 30,157 (Direct) | View |
| 2024-01-01 Exercise | 2024-04-12 4:55 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 1,675 | $0 | 48,746 (Direct) | View |
| 2024-01-01 Tax Withholding | 2024-04-12 4:55 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 539 | $2.79 | 48,746 (Direct) | View |
| 2024-01-01 Exercise | 2024-04-12 4:52 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer | 1,675 | $0 | 50,265 (Direct) | View |
| 2024-01-01 Tax Withholding | 2024-04-12 4:52 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer | 368 | $2.79 | 50,265 (Direct) | View |
| 2024-01-01 Exercise | 2024-04-12 4:50 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer | 1,675 | $0 | 39,900 (Direct) | View |
| 2024-01-01 Tax Withholding | 2024-04-12 4:50 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer | 368 | $2.79 | 39,900 (Direct) | View |